Category: Covid-19

This generic protocol for ECDC studies describes the design and methods for a prospective multi-country cohort study of hospital-based healthcare workers (HCWs) to evaluate the effectiveness of COVID-19 vaccine in preventing laboratory-confirmed SARS-CoV-2 infection.

This document reports on one of ECDC’s multi-country studies in the hospital setting to measure product-specific COVID-19 VE against any laboratory-confirmed SARS-CoV-2 infection among healthcare workers (HCWs) eligible for vaccination.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-12 November 2022 and includes updates on monitoring the FIFA World Cup in Qatar, measles, MERS-CoV, COVID-19, monkeypox, West Nile virus, diphtheria, Ebola virus disease, avian influenza, seasonal influenza, and S. sonnei.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-12 November 2022 and includes updates on monitoring the FIFA World Cup in Qatar, measles, MERS-CoV, COVID-19, monkeypox, West Nile virus, diphtheria, Ebola virus disease, avian influenza, seasonal influenza, and S. sonnei.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 October-5 November 2022 and includes updates on chikungunya, dengue, COVID-19, increase in hepatitis cases in children, monkeypox, West Nile virus, Ebola virus disease due to Sudan ebolavirus, and seasonal influenza.

The primary aim of this systematic review and meta-analysis was to estimate the prevalence of symptoms of post COVID-19 condition, stratified by recruitment setting (community, hospital and Intensive Care Unit (ICU)) as a proxy for disease severity.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 October 2022 and includes updates on COVID-19, monkeypox, West Nile virus, diphtheria among migrants, Ebola virus disease, seasonal influenza, cholera, and respiratory syncytial virus (RSV).

This report presents the results of a pilot study aimed at assisting EU/EEA countries with SARS-CoV-2 antigenic characterisation.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 October 2022 and includes updates on COVID-19, monkeypox, diphtheria, West Nile virus, measles, Ebola virus disease, cholera, influenza A(H5N6), poliomyelitis, seasonal influenza, and Avian influenza A(H5N1) in mink.

At least five EU/EEA countries have detected the circulation of the SARS-CoV-2 variant sub-lineage BQ.1 during week 40, 2022.